Omeros (OMER) EBIT Margin Growth (3y) (2013 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 63,640.00 |
| Jun 30, 2021 | 169,173.00 |
| Mar 31, 2021 | 152,860.00 |
| Dec 31, 2020 | -21,544.00 |
| Sep 30, 2020 | -7,378.00 |
| Jun 30, 2020 | -13,497.00 |
| Mar 31, 2020 | 322.00 |
| Dec 31, 2019 | 2,095.00 |
| Sep 30, 2019 | 6,945.00 |
| Jun 30, 2019 | 7,434.00 |
| Mar 31, 2019 | 17,385.00 |
| Dec 31, 2018 | 18,635.00 |
| Sep 30, 2018 | -17,690.00 |
| Jun 30, 2018 | -134,897.00 |
| Mar 31, 2018 | 287,749.00 |
| Dec 31, 2017 | 1.10 Mn |
| Sep 30, 2017 | 798,201.00 |
| Jun 30, 2017 | 3.82 Mn |
| Mar 31, 2017 | 1.56 Mn |
| Dec 31, 2016 | 813,416.00 |
| Sep 30, 2016 | 674,745.00 |
| Jun 30, 2016 | 929,075.00 |
| Mar 31, 2016 | 65,288.00 |
| Dec 31, 2015 | 20,561.00 |
| Sep 30, 2015 | 32,773.00 |
| Jun 30, 2015 | 3,923.00 |
| Mar 31, 2015 | -408,156.00 |
| Dec 31, 2014 | -1.02 Mn |
| Sep 30, 2014 | -738,109.00 |
| Jun 30, 2014 | -3.78 Mn |
| Mar 31, 2014 | -1.52 Mn |
| Dec 31, 2013 | -734,929.00 |
| Sep 30, 2013 | -390,526.00 |
| Jun 30, 2013 | -786,398.00 |